About abciximab
Glycoprotein IIb/IIIa platelet inhibitor
Used for
- Prevents clot-related heart complications during coronary angioplasty or related procedures.
Usual adult dose
0.25 mg/kg intravenously before the procedure, then 0.125 micrograms/kg/minute for 12 hours; maximum 10 micrograms/minute.
Common side effects
- Bleeding
- Low platelet count
- Low blood pressure
- Nausea
Important warnings
- Major bleeding can occur, especially with other blood-thinning medicines.
- Use only during specialist-supervised coronary procedures.
- Monitor blood counts and bleeding closely.
- Avoid repeat treatment within 30 days because severe low platelet counts may occur.
Pregnancy
Use only if clearly needed; pregnancy safety information is limited.
Breastfeeding
It is not known whether abciximab passes into breast milk.
Interactions
- Heparin, warfarin, and other anticoagulants increase bleeding risk.
- Aspirin and other antiplatelet medicines increase bleeding risk.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.